Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,118.00
Bid: 1,125.00
Ask: 1,128.00
Change: 26.00 (2.38%)
Spread: 3.00 (0.267%)
Open: 1,094.00
High: 1,128.00
Low: 1,080.00
Prev. Close: 1,092.00
BUR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Burford Receives $26m From Innovative Investment

3 Jun 2014 07:00

RNS Number : 6471I
Burford Capital
03 June 2014
 



3 June 2014

BURFORD CAPITAL RECEIVES $26 MILLION FROM INNOVATIVE

CORPORATE DEBT FACILITY BACKED BY ARBITRATION CLAIM

 

Ground-breaking use of pending claim to drive down corporate borrowing costs

expands potential of litigation finance market

 

Burford Capital Limited, the world's largest provider of investment capital and risk solutions for litigation, today announces that it received $26 million in proceeds from an innovative transaction where Burford1 provided a corporate debt facility linked to an arbitration claim. Burford's counterparty was Rurelec PLC, a publicly-traded owner, operator and developer of power generation capacity internationally.

 

Burford's 2012 facility permitted Rurelec to monetize the value of its arbitration claim and use that value to obtain a conventional, fully recourse loan from Burford at a lower interest rate than would otherwise have been available to Rurelec in the debt markets. Rurelec used the Burford facility to expand its business while it awaited the outcome of its arbitration.

 

Commenting on the transaction, Rurelec's Chairman Colin Emson said: "We were able to use a pending arbitration claim to obtain innovative corporate financing from Burford that lowered our cost of capital and helped our business expand. The Burford team was smart, fast and decisive. The ability to monetize a pending claim is something that we could only have achieved with Burford."

 

The Rurelec transaction was profitable for Burford, which earned an $11 million net profit on a $15 million investment, generating a 73% return and a 34% IRR. However, what is noteworthy about this transaction is its innovative structure.

 

Litigation finance is often thought of as non-recourse financing to pay the costs of bringing a piece of litigation. The reality is considerably broader and more diverse, and Burford deploys capital in many different ways, all centered around evaluating and monetizing a contingent litigation asset.

 

In this case, Rurelec was pursuing an arbitration claim against Bolivia for the expropriation of one of Rurelec's power plants. Rurelec did not need capital to pay its lawyers. Rather, it needed capital to continue to grow its business - but lenders wanted very high interest rates. Unlike a traditional lender, Burford was able to evaluate the value of Rurelec's pending arbitration claim, and thus was able to provide the following facility:

· A fully recourse, secured $15 million senior loan at a 12% capitalized interest rate

· A contingent value right to receive a portion of the ultimate arbitration award, expressed on a sliding scale based on time and amount

 

Rurelec then won its claim, extracted payment from Bolivia, and paid off Burford.

The result was that Rurelec received the capital it needed at a reasonable price, and was able to monetize a contingent asset (its arbitration claim) for which its lenders and shareholders were not giving it financial credit. Meanwhile, Burford was able to earn appealing returns in a transaction with lower risk of loss by putting its specialized expertise to work.

 

1 Burford Capital Limited and the relevant wholly-owned subsidiary, Salvia Investments Limited, will collectively be referred to as "Burford".

 

Burford is not usually permitted under the terms of its agreements with its counterparties to make any sort of public announcement or disclosure about individual investments. However, Rurelec's own disclosure obligations and its consent make this exception possible.

 

Burford is pleased to be able to share the details of this transaction publicly, both to advance understanding of the reality of litigation finance and to encourage other creative lawyers, bankers and financial managers to pursue the monetization of pending claims.

 

Christopher Bogart, Burford's CEO, commented: "Litigation finance is too often thought of in its most basic form, which does not reflect the range of innovative investment structures we are able to utilise. In this case, by recognising and assigning value to a pending arbitration claim, Burford was able to structure an investment which allowed Rurelec to pursue its expansion. This is a good demonstration that the benefits of litigation finance go far beyond that of simply helping to pay legal fees, and in many cases can provide an effective alternative method of financing to help companies achieve their strategic goals."

 

Rurelec was represented by Freshfields Bruckhaus Deringer in the arbitration proceeding and by Skadden, Arps, Slate, Meagher & Flom in the financing transaction. Burford performed its own internal evaluation of the arbitration claim with its own experienced team, and was represented by Latham & Watkins in the financing transaction.

 

For further information, please contact:

 

Macquarie Capital (Europe) Limited - NOMAD and Joint Broker

Steve Baldwin +44 (0)20 3037 2000

Nicholas Harland

 

Espirito Santo Investment Bank - Joint Broker

John Llewellyn-Lloyd +44 (0)20 7456 9191

Harry Stockdale

 

RBC Capital Markets - Joint Broker

Oliver Hearsey +44 (0)20 7653 4000

 

FTI Consulting - PR for Burford Capital

Edward Berry +44 (0)20 3727 1046

Laura Ewart +44 (0)20 3727 1160

 

About Burford Capital

 

Burford Capital is the world's largest provider of investment capital and risk solutions for litigation with the largest and most experienced dedicated team in the industry. Burford is publicly traded on the London Stock Exchange's AIM market under the ticker symbol BUR. Burford provides a broad range of corporate finance and insurance solutions to lawyers and clients engaged in significant litigation and arbitration around the world.

 

For more information about Burford, visit www.burfordcapital.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSSLFMEFLSEDM
Date   Source Headline
4th Jul 20235:00 pmRNSTransaction in Own Shares
3rd Jul 20232:00 pmRNSCompletion of Share Purchases & PDMR Transactions
29th Jun 202311:14 amRNSIntended Purchases of Ordinary Shares
26th Jun 20236:00 pmRNSDirector/PDMR Shareholding
26th Jun 20232:08 pmRNSUpdate & Release Date for 2Q23 Results
26th Jun 20232:07 pmRNSNotice of Early Redemption of Bonds due 2024
26th Jun 20232:05 pmRNSClosing of Private Offering of Senior Notes
23rd Jun 20237:00 amRNSPricing of Senior Notes Offering
22nd Jun 20235:22 pmRNSDirector/PDMR Shareholding
20th Jun 20231:00 pmRNSPrivate Offering of Senior Notes
13th Jun 202312:00 pmRNS1Q23 Results & Quarterly Report
8th Jun 20233:00 pmRNSNotice of 1Q23 Results & Results Call Details
6th Jun 202312:00 pmRNSNotice of Retail Shareholder Call on June 21, 2023
6th Jun 202312:00 pmRNSNotice of 2023 AGM
2nd Jun 202312:00 pmRNSSterling FX Rate for Second 2022 Interim Dividend
16th May 202312:00 pmRNSAvailability of 2022 Annual Report
16th May 202312:00 pmRNSAnnual results for year ended December 31, 2022
3rd May 20237:00 amRNSNotice of 2022 Results and Update on Accounting
3rd Apr 20237:30 amRNSRestoration - Burford Capital Limited
3rd Apr 20237:00 amRNSStatement on YPF Summary Judgment Ruling
31st Mar 20234:57 pmRNSSuspension - Burford Capital Limited
31st Mar 20234:14 pmRNSStatement re Petersen and Eton Park Matters
29th Mar 20233:00 pmRNSTransaction in Own Shares
22nd Mar 20234:00 pmRNSDirector/PDMR Shareholding
16th Mar 20237:00 amRNSUpdate on 2022 Business Activity
3rd Jan 202312:00 pmRNSUpdate on and Completion of Share Purchases by EBT
30th Dec 20221:13 pmRNSDirector/PDMR Shareholding
28th Dec 202212:00 pmRNSUpdate on Share Purchases by EBT
16th Dec 202212:00 pmRNSUpdate on Share Purchases by EBT
9th Dec 20225:00 pmRNSDirector/PDMR Shareholding
9th Dec 20227:00 amRNSIntended Share Purchases by Employee Benefit Trust
25th Nov 202212:00 pmRNSDirector/PDMR Bondholding
16th Nov 202212:00 pmRNSAppointment of Joint Corporate Broker
9th Nov 202212:00 pmRNSSterling FX Rate for 2022 Interim Dividend
1st Nov 20221:23 pmRNSBurford Capital Releases 2022 GC Survey Results
13th Sep 20223:27 pmRNSBurford Capital-Report on Class Action Recoveries
6th Sep 20227:00 amRNSJordan Licht Appointed Chief Financial Officer
26th Aug 20222:00 pmRNSDirector/PDMR Shareholding
24th Aug 20222:00 pmRNSDirector/PDMR Shareholding
16th Aug 20222:00 pmRNSPDMR Shareholding and Transaction in Own Shares
9th Aug 202212:01 pmRNSDr. Rukia Baruti Appointed as Board Director
9th Aug 202212:00 pmRNSInterim Results for six months ended 30 June 2022
26th Jul 20222:00 pmRNSTR-1: Notification of Major Holdings
26th Jul 202212:00 pmRNSNotice of 1H22 Results Date & Results Call Details
25th Jul 20222:00 pmRNSTR-1: Notification of Major Holdings
27th Jun 202211:30 amRNSDirector/PDMR Shareholding
15th Jun 20225:30 pmRNSPurchases of Shares for NED Plan and PDMR Notices
13th Jun 20227:00 amRNS$350 Million Post-Settlement Investment Fund Close
10th Jun 20223:00 pmRNSIntended Purchases of Ordinary Shares
7th Jun 20223:00 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.